Blog
NeuroAiD at World Congress of Neurology
Moleac’s flagship product, NeuroAiD, will be presented at the 23rd Word Congress of Neurology during oral abstract presentations by A/Prof. Alice Theadom from New-Zealand. A Randomized, Placebo-controlled Pilot Trial to Investigate the Safety and Efficacy of MLC901...
NeuroAiD presentations at European Stroke Conference
NeuroAiD, Moleac’s main product, will be presented at the 26th European Stroke Conference on 24th May during abstract presentations on the 24th and 26th May by A/Prof. Narayanaswamy Venketasubrmanian: Comparison of Long-term Spontaneous Functional Recovery and...
NeuroAiD presentations at European Stroke Organisation Conference
NeuroAiD, Moleac’s main product, will be presented at the 3rd European Stroke Organisation Conference on 16th May during the following poster presentations: Synergistic Effect of Combining MLC601 and Rehabilitation on Post-stroke Recovery – The CHIMES Study Targeting...
